Contract Research and Manufacturing Service (CRAMS) Market in India 2025-2029

Publisher TechNavio

Published Feb 15, 2025

Length 197 Pages

SKU # INF19639223

Description

Contract Research And Manufacturing Service (CRAMS) Market In India 2025-2029

The contract research and manufacturing service (CRAMS) market in India is forecasted to grow by USD 17114.6 million during 2024-2029, accelerating at a CAGR of 11.8% during the forecast period. The report on the contract research and manufacturing service (CRAMS) market in India provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by diverse range of service offerings by CRAMS providers, availability of cost-effective solutions for research, development, and manufacturing services, and presence of highly skilled workforce in pharmaceutical sciences and biotechnology.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data. For further information on this report, please visit - https://www.technavio.com/report/report/india-contract-research-and-manufacturing-service-CRAMS-market-in-2024-2028-industry-analysis

Technavio's contract research and manufacturing service (CRAMS) market in India is segmented as below:

By Service

Manufacturing
Research

By Therapeutic Area

Cardiovascular
Infectious disease
Endocrine disease
Oncology
Others

By End-user

Pharmaceutical and biopharmaceutical companies
Medical device companies
Academic and research institutes

By Technology

Bioinformatics
Combinatorial chemistry
High-throughput screening
Spectroscopy
Others

By Geographical Landscape

APAC

This study identifies the technological advancements in CRAMS as one of the prime reasons driving the contract research and manufacturing service (CRAMS) market in India growth during the next few years. Also, increasing number of US fda-approved manufacturing facilities and increasing outsourcing of research and manufacturing activities by smes will lead to sizable demand in the market.

The report on the contract research and manufacturing service (CRAMS) market in India covers the following areas:

Contract Research And Manufacturing Service (CRAMS) Market in India sizing
Contract Research And Manufacturing Service (CRAMS) Market in India forecast
Contract Research And Manufacturing Service (CRAMS) Market in India industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading contract research and manufacturing service (CRAMS) market in India vendors that include Aragen Life Sciences Pvt. Ltd., Arch Pharmalabs Ltd., Aurobindo Pharma Ltd., Bhagwati Organics Pvt. Ltd., Biocon Ltd., Dhanuka Agritech Ltd., Dishman Carbogen Amcis Ltd., Divis Laboratories Ltd., Ind-Swift Laboratories Ltd., Jubilant Pharmova Ltd., Lupin Ltd., Merck and Co. Inc., MSN Laboratories, Murli Krishna Pharma Pvt. Ltd., Onyx Scientific Ltd., Piramal Enterprises Ltd., Sun Pharmaceutical Industries Ltd., TCG Lifesciences Pvt. Ltd., and Wockhardt Ltd.. Also, the contract research and manufacturing service (CRAMS) market in India analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Country Market Characteristics; Executive Summary - Chart on Market Segmentation by Service; Executive Summary - Chart on Market Segmentation by Therapeutic Area; Executive Summary - Chart on Market Segmentation by End-user; Executive Summary - Chart on Market Segmentation by Technology; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value chain analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2024; 4.4 Market outlook: Forecast for 2024-2029; Chart on India - Market size and forecast 2024-2029 ($ million); Data Table on India - Market size and forecast 2024-2029 ($ million); Chart on India: Year-over-year growth 2024-2029 (%); Data Table on India: Year-over-year growth 2024-2029 (%)
5 Historic Market Size: 5.1 Contract Research And Manufacturing Service (CRAMS) Market in India 2019 - 2023; Historic Market Size - Data Table on Contract Research And Manufacturing Service (CRAMS) Market in India 2019 - 2023 ($ million); 5.2 Service segment analysis 2019 - 2023; Historic Market Size - Service Segment 2019 - 2023 ($ million); 5.3 Therapeutic Area segment analysis 2019 - 2023; Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ million); 5.4 End-user segment analysis 2019 - 2023; Historic Market Size - End-user Segment 2019 - 2023 ($ million); 5.5 Technology segment analysis 2019 - 2023; Historic Market Size - Technology Segment 2019 - 2023 ($ million)
6 Qualitative Analysis: 6.1 Impact of AI on Contract Research and Manufacturing Service (CRAMS) Market in India
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2024 and 2029; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2024 and 2029; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2024 and 2029; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2024 and 2029; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2024 and 2029; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2024 and 2029; 7.7 Market condition; Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Service: 8.1 Market segments; Chart on Service - Market share 2024-2029 (%); Data Table on Service - Market share 2024-2029 (%); 8.2 Comparison by Service; Chart on Comparison by Service; Data Table on Comparison by Service; 8.3 Manufacturing - Market size and forecast 2024-2029; Chart on Manufacturing - Market size and forecast 2024-2029 ($ million); Data Table on Manufacturing - Market size and forecast 2024-2029 ($ million); Chart on Manufacturing - Year-over-year growth 2024-2029 (%); Data Table on Manufacturing - Year-over-year growth 2024-2029 (%); 8.4 Research - Market size and forecast 2024-2029; Chart on Research - Market size and forecast 2024-2029 ($ million); Data Table on Research - Market size and forecast 2024-2029 ($ million); Chart on Research - Year-over-year growth 2024-2029 (%); Data Table on Research - Year-over-year growth 2024-2029 (%); 8.5 Market opportunity by Service; Market opportunity by Service ($ million); Data Table on Market opportunity by Service ($ million)
9 Market Segmentation by Therapeutic Area: 9.1 Market segments; Chart on Therapeutic Area - Market share 2024-2029 (%); Data Table on Therapeutic Area - Market share 2024-2029 (%); 9.2 Comparison by Therapeutic Area; Chart on Comparison by Therapeutic Area; Data Table on Comparison by Therapeutic Area; 9.3 Cardiovascular - Market size and forecast 2024-2029; Chart on Cardiovascular - Market size and forecast 2024-2029 ($ million); Data Table on Cardiovascular - Market size and forecast 2024-2029 ($ million); Chart on Cardiovascular - Year-over-year growth 2024-2029 (%); Data Table on Cardiovascular - Year-over-year growth 2024-2029 (%); 9.4 Infectious disease - Market size and forecast 2024-2029; Chart on Infectious disease - Market size and forecast 2024-2029 ($ million); Data Table on Infectious disease - Market size and forecast 2024-2029 ($ million); Chart on Infectious disease - Year-over-year growth 2024-2029 (%); Data Table on Infectious disease - Year-over-year growth 2024-2029 (%); 9.5 Endocrine disease - Market size and forecast 2024-2029; Chart on Endocrine disease - Market size and forecast 2024-2029 ($ million); Data Table on Endocrine disease - Market size and forecast 2024-2029 ($ million); Chart on Endocrine disease - Year-over-year growth 2024-2029 (%); Data Table on Endocrine disease - Year-over-year growth 2024-2029 (%); 9.6 Oncology - Market size and forecast 2024-2029; Chart on Oncology - Market size and forecast 2024-2029 ($ million); Data Table on Oncology - Market size and forecast 2024-2029 ($ million); Chart on Oncology - Year-over-year growth 2024-2029 (%); Data Table on Oncology - Year-over-year growth 2024-2029 (%); 9.7 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ million); Data Table on Others - Market size and forecast 2024-2029 ($ million); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 9.8 Market opportunity by Therapeutic Area; Market opportunity by Therapeutic Area ($ million); Data Table on Market opportunity by Therapeutic Area ($ million)
10 Market Segmentation by End-user: 10.1 Market segments; Chart on End-user - Market share 2024-2029 (%); Data Table on End-user - Market share 2024-2029 (%); 10.2 Comparison by End-user; Chart on Comparison by End-user; Data Table on Comparison by End-user; 10.3 Pharmaceutical and biopharmaceutical companies - Market size and forecast 2024-2029; Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2024-2029 ($ million); Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2024-2029 ($ million); Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2024-2029 (%); Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2024-2029 (%); 10.4 Medical device companies - Market size and forecast 2024-2029; Chart on Medical device companies - Market size and forecast 2024-2029 ($ million); Data Table on Medical device companies - Market size and forecast 2024-2029 ($ million); Chart on Medical device companies - Year-over-year growth 2024-2029 (%); Data Table on Medical device companies - Year-over-year growth 2024-2029 (%); 10.5 Academic and research institutes - Market size and forecast 2024-2029; Chart on Academic and research institutes - Market size and forecast 2024-2029 ($ million); Data Table on Academic and research institutes - Market size and forecast 2024-2029 ($ million); Chart on Academic and research institutes - Year-over-year growth 2024-2029 (%); Data Table on Academic and research institutes - Year-over-year growth 2024-2029 (%); 10.6 Market opportunity by End-user; Market opportunity by End-user ($ million); Data Table on Market opportunity by End-user ($ million)
11 Market Segmentation by Technology: 11.1 Market segments; Chart on Technology - Market share 2024-2029 (%); Data Table on Technology - Market share 2024-2029 (%); 11.2 Comparison by Technology; Chart on Comparison by Technology; Data Table on Comparison by Technology; 11.3 Bioinformatics - Market size and forecast 2024-2029; Chart on Bioinformatics - Market size and forecast 2024-2029 ($ million); Data Table on Bioinformatics - Market size and forecast 2024-2029 ($ million); Chart on Bioinformatics - Year-over-year growth 2024-2029 (%); Data Table on Bioinformatics - Year-over-year growth 2024-2029 (%); 11.4 Combinatorial chemistry - Market size and forecast 2024-2029; Chart on Combinatorial chemistry - Market size and forecast 2024-2029 ($ million); Data Table on Combinatorial chemistry - Market size and forecast 2024-2029 ($ million); Chart on Combinatorial chemistry - Year-over-year growth 2024-2029 (%); Data Table on Combinatorial chemistry - Year-over-year growth 2024-2029 (%); 11.5 High-throughput screening - Market size and forecast 2024-2029; Chart on High-throughput screening - Market size and forecast 2024-2029 ($ million); Data Table on High-throughput screening - Market size and forecast 2024-2029 ($ million); Chart on High-throughput screening - Year-over-year growth 2024-2029 (%); Data Table on High-throughput screening - Year-over-year growth 2024-2029 (%); 11.6 Spectroscopy - Market size and forecast 2024-2029; Chart on Spectroscopy - Market size and forecast 2024-2029 ($ million); Data Table on Spectroscopy - Market size and forecast 2024-2029 ($ million); Chart on Spectroscopy - Year-over-year growth 2024-2029 (%); Data Table on Spectroscopy - Year-over-year growth 2024-2029 (%); 11.7 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ million); Data Table on Others - Market size and forecast 2024-2029 ($ million); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 11.8 Market opportunity by Technology; Market opportunity by Technology ($ million); Data Table on Market opportunity by Technology ($ million)
12 Customer Landscape: 12.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Drivers, Challenges, and Opportunity/Restraints: 13.1 Market drivers; 13.2 Market challenges; 13.3 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029; 13.4 Market opportunities/restraints
14 Competitive Landscape: 14.1 Overview; 14.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 14.3 Landscape disruption; Overview on factors of disruption; 14.4 Industry risks; Impact of key risks on business
15 Competitive Analysis: 15.1 Companies profiled; Companies covered; 15.2 Company ranking index; Company ranking index; 15.3 Market positioning of companies; Matrix on companies position and classification; 15.4 Aragen Life Sciences Pvt. Ltd.; Aragen Life Sciences Pvt. Ltd. - Overview; Aragen Life Sciences Pvt. Ltd. - Product / Service; Aragen Life Sciences Pvt. Ltd. - Key offerings; SWOT; 15.5 Aurobindo Pharma Ltd.; Aurobindo Pharma Ltd. - Overview; Aurobindo Pharma Ltd. - Product / Service; Aurobindo Pharma Ltd. - Key offerings; SWOT; 15.6 Biocon Ltd.; Biocon Ltd. - Overview; Biocon Ltd. - Business segments; Biocon Ltd. - Key offerings; Biocon Ltd. - Segment focus; SWOT; 15.7 Dhanuka Agritech Ltd.; Dhanuka Agritech Ltd. - Overview; Dhanuka Agritech Ltd. - Business segments; Dhanuka Agritech Ltd. - Key offerings; Dhanuka Agritech Ltd. - Segment focus; SWOT; 15.8 Dishman Carbogen Amcis Ltd.; Dishman Carbogen Amcis Ltd. - Overview; Dishman Carbogen Amcis Ltd. - Business segments; Dishman Carbogen Amcis Ltd. - Key offerings; Dishman Carbogen Amcis Ltd. - Segment focus; SWOT; 15.9 Divis Laboratories Ltd.; Divis Laboratories Ltd. - Overview; Divis Laboratories Ltd. - Product / Service; Divis Laboratories Ltd. - Key offerings; SWOT; 15.10 Jubilant Pharmova Ltd.; Jubilant Pharmova Ltd. - Overview; Jubilant Pharmova Ltd. - Business segments; Jubilant Pharmova Ltd. - Key news; Jubilant Pharmova Ltd. - Key offerings; Jubilant Pharmova Ltd. - Segment focus; SWOT; 15.11 Lupin Ltd.; Lupin Ltd. - Overview; Lupin Ltd. - Business segments; Lupin Ltd. - Key news; Lupin Ltd. - Key offerings; Lupin Ltd. - Segment focus; SWOT; 15.12 Merck and Co. Inc.; Merck and Co. Inc. - Overview; Merck and Co. Inc. - Business segments; Merck and Co. Inc. - Key news; Merck and Co. Inc. - Key offerings; Merck and Co. Inc. - Segment focus; SWOT; 15.13 MSN Laboratories; MSN Laboratories - Overview; MSN Laboratories - Product / Service; MSN Laboratories - Key offerings; SWOT; 15.14 Onyx Scientific Ltd.; Onyx Scientific Ltd. - Overview; Onyx Scientific Ltd. - Product / Service; Onyx Scientific Ltd. - Key offerings; SWOT; 15.15 Piramal Enterprises Ltd.; Piramal Enterprises Ltd. - Overview; Piramal Enterprises Ltd. - Product / Service; Piramal Enterprises Ltd. - Key offerings; SWOT; 15.16 Sun Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd. - Overview; Sun Pharmaceutical Industries Ltd. - Product / Service; Sun Pharmaceutical Industries Ltd. - Key news; Sun Pharmaceutical Industries Ltd. - Key offerings; SWOT; 15.17 TCG Lifesciences Pvt. Ltd.; TCG Lifesciences Pvt. Ltd. - Overview; TCG Lifesciences Pvt. Ltd. - Product / Service; TCG Lifesciences Pvt. Ltd. - Key offerings; SWOT; 15.18 Wockhardt Ltd.; Wockhardt Ltd. - Overview; Wockhardt Ltd. - Business segments; Wockhardt Ltd. - Key offerings; Wockhardt Ltd. - Segment focus; SWOT
16 Appendix: 16.1 Scope of the report; 16.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 16.3 Currency conversion rates for US$; Currency conversion rates for US$; 16.4 Research methodology; Research methodology; 16.5 Data procurement; Information sources; 16.6 Data validation; Data validation; 16.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 16.8 Data synthesis; Data synthesis; 16.9 360 degree market analysis; 360 degree market analysis; 16.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Country Market Characteristics; Exhibits4: Executive Summary - Chart on Market Segmentation by Service; Exhibits5: Executive Summary - Chart on Market Segmentation by Therapeutic Area; Exhibits6: Executive Summary - Chart on Market Segmentation by End-user; Exhibits7: Executive Summary - Chart on Market Segmentation by Technology; Exhibits8: Executive Summary - Chart on Company Market Positioning; Exhibits9: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits10: Overview on criticality of inputs and factors of differentiation; Exhibits11: Overview on factors of disruption; Exhibits12: Impact of drivers and challenges in 2024 and 2029; Exhibits13: Parent Market; Exhibits14: Data Table on - Parent Market; Exhibits15: Market characteristics analysis; Exhibits16: Value chain analysis; Exhibits17: Offerings of companies included in the market definition; Exhibits18: Market segments; Exhibits19: Chart on India - Market size and forecast 2024-2029 ($ million); Exhibits20: Data Table on India - Market size and forecast 2024-2029 ($ million); Exhibits21: Chart on India: Year-over-year growth 2024-2029 (%); Exhibits22: Data Table on India: Year-over-year growth 2024-2029 (%); Exhibits23: Historic Market Size - Data Table on Contract Research And Manufacturing Service (CRAMS) Market in India 2019 - 2023 ($ million); Exhibits24: Historic Market Size - Service Segment 2019 - 2023 ($ million); Exhibits25: Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ million); Exhibits26: Historic Market Size - End-user Segment 2019 - 2023 ($ million); Exhibits27: Historic Market Size - Technology Segment 2019 - 2023 ($ million); Exhibits28: Five forces analysis - Comparison between 2024 and 2029; Exhibits29: Bargaining power of buyers - Impact of key factors 2024 and 2029; Exhibits30: Bargaining power of suppliers - Impact of key factors in 2024 and 2029; Exhibits31: Threat of new entrants - Impact of key factors in 2024 and 2029; Exhibits32: Threat of substitutes - Impact of key factors in 2024 and 2029; Exhibits33: Threat of rivalry - Impact of key factors in 2024 and 2029; Exhibits34: Chart on Market condition - Five forces 2024 and 2029; Exhibits35: Chart on Service - Market share 2024-2029 (%); Exhibits36: Data Table on Service - Market share 2024-2029 (%); Exhibits37: Chart on Comparison by Service; Exhibits38: Data Table on Comparison by Service; Exhibits39: Chart on Manufacturing - Market size and forecast 2024-2029 ($ million); Exhibits40: Data Table on Manufacturing - Market size and forecast 2024-2029 ($ million); Exhibits41: Chart on Manufacturing - Year-over-year growth 2024-2029 (%); Exhibits42: Data Table on Manufacturing - Year-over-year growth 2024-2029 (%); Exhibits43: Chart on Research - Market size and forecast 2024-2029 ($ million); Exhibits44: Data Table on Research - Market size and forecast 2024-2029 ($ million); Exhibits45: Chart on Research - Year-over-year growth 2024-2029 (%); Exhibits46: Data Table on Research - Year-over-year growth 2024-2029 (%); Exhibits47: Market opportunity by Service ($ million); Exhibits48: Data Table on Market opportunity by Service ($ million); Exhibits49: Chart on Therapeutic Area - Market share 2024-2029 (%); Exhibits50: Data Table on Therapeutic Area - Market share 2024-2029 (%); Exhibits51: Chart on Comparison by Therapeutic Area; Exhibits52: Data Table on Comparison by Therapeutic Area; Exhibits53: Chart on Cardiovascular - Market size and forecast 2024-2029 ($ million); Exhibits54: Data Table on Cardiovascular - Market size and forecast 2024-2029 ($ million); Exhibits55: Chart on Cardiovascular - Year-over-year growth 2024-2029 (%); Exhibits56: Data Table on Cardiovascular - Year-over-year growth 2024-2029 (%); Exhibits57: Chart on Infectious disease - Market size and forecast 2024-2029 ($ million); Exhibits58: Data Table on Infectious disease - Market size and forecast 2024-2029 ($ million); Exhibits59: Chart on Infectious disease - Year-over-year growth 2024-2029 (%); Exhibits60: Data Table on Infectious disease - Year-over-year growth 2024-2029 (%); Exhibits61: Chart on Endocrine disease - Market size and forecast 2024-2029 ($ million); Exhibits62: Data Table on Endocrine disease - Market size and forecast 2024-2029 ($ million); Exhibits63: Chart on Endocrine disease - Year-over-year growth 2024-2029 (%); Exhibits64: Data Table on Endocrine disease - Year-over-year growth 2024-2029 (%); Exhibits65: Chart on Oncology - Market size and forecast 2024-2029 ($ million); Exhibits66: Data Table on Oncology - Market size and forecast 2024-2029 ($ million); Exhibits67: Chart on Oncology - Year-over-year growth 2024-2029 (%); Exhibits68: Data Table on Oncology - Year-over-year growth 2024-2029 (%); Exhibits69: Chart on Others - Market size and forecast 2024-2029 ($ million); Exhibits70: Data Table on Others - Market size and forecast 2024-2029 ($ million); Exhibits71: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits72: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits73: Market opportunity by Therapeutic Area ($ million); Exhibits74: Data Table on Market opportunity by Therapeutic Area ($ million); Exhibits75: Chart on End-user - Market share 2024-2029 (%); Exhibits76: Data Table on End-user - Market share 2024-2029 (%); Exhibits77: Chart on Comparison by End-user; Exhibits78: Data Table on Comparison by End-user; Exhibits79: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2024-2029 ($ million); Exhibits80: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2024-2029 ($ million); Exhibits81: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2024-2029 (%); Exhibits82: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2024-2029 (%); Exhibits83: Chart on Medical device companies - Market size and forecast 2024-2029 ($ million); Exhibits84: Data Table on Medical device companies - Market size and forecast 2024-2029 ($ million); Exhibits85: Chart on Medical device companies - Year-over-year growth 2024-2029 (%); Exhibits86: Data Table on Medical device companies - Year-over-year growth 2024-2029 (%); Exhibits87: Chart on Academic and research institutes - Market size and forecast 2024-2029 ($ million); Exhibits88: Data Table on Academic and research institutes - Market size and forecast 2024-2029 ($ million); Exhibits89: Chart on Academic and research institutes - Year-over-year growth 2024-2029 (%); Exhibits90: Data Table on Academic and research institutes - Year-over-year growth 2024-2029 (%); Exhibits91: Market opportunity by End-user ($ million); Exhibits92: Data Table on Market opportunity by End-user ($ million); Exhibits93: Chart on Technology - Market share 2024-2029 (%); Exhibits94: Data Table on Technology - Market share 2024-2029 (%); Exhibits95: Chart on Comparison by Technology; Exhibits96: Data Table on Comparison by Technology; Exhibits97: Chart on Bioinformatics - Market size and forecast 2024-2029 ($ million); Exhibits98: Data Table on Bioinformatics - Market size and forecast 2024-2029 ($ million); Exhibits99: Chart on Bioinformatics - Year-over-year growth 2024-2029 (%); Exhibits100: Data Table on Bioinformatics - Year-over-year growth 2024-2029 (%); Exhibits101: Chart on Combinatorial chemistry - Market size and forecast 2024-2029 ($ million); Exhibits102: Data Table on Combinatorial chemistry - Market size and forecast 2024-2029 ($ million); Exhibits103: Chart on Combinatorial chemistry - Year-over-year growth 2024-2029 (%); Exhibits104: Data Table on Combinatorial chemistry - Year-over-year growth 2024-2029 (%); Exhibits105: Chart on High-throughput screening - Market size and forecast 2024-2029 ($ million); Exhibits106: Data Table on High-throughput screening - Market size and forecast 2024-2029 ($ million); Exhibits107: Chart on High-throughput screening - Year-over-year growth 2024-2029 (%); Exhibits108: Data Table on High-throughput screening - Year-over-year growth 2024-2029 (%); Exhibits109: Chart on Spectroscopy - Market size and forecast 2024-2029 ($ million); Exhibits110: Data Table on Spectroscopy - Market size and forecast 2024-2029 ($ million); Exhibits111: Chart on Spectroscopy - Year-over-year growth 2024-2029 (%); Exhibits112: Data Table on Spectroscopy - Year-over-year growth 2024-2029 (%); Exhibits113: Chart on Others - Market size and forecast 2024-2029 ($ million); Exhibits114: Data Table on Others - Market size and forecast 2024-2029 ($ million); Exhibits115: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits116: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits117: Market opportunity by Technology ($ million); Exhibits118: Data Table on Market opportunity by Technology ($ million); Exhibits119: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits120: Impact of drivers and challenges in 2024 and 2029; Exhibits121: Overview on criticality of inputs and factors of differentiation; Exhibits122: Overview on factors of disruption; Exhibits123: Impact of key risks on business; Exhibits124: Companies covered; Exhibits125: Company ranking index; Exhibits126: Matrix on companies position and classification; Exhibits127: Aragen Life Sciences Pvt. Ltd. - Overview; Exhibits128: Aragen Life Sciences Pvt. Ltd. - Product / Service; Exhibits129: Aragen Life Sciences Pvt. Ltd. - Key offerings; Exhibits130: SWOT; Exhibits131: Aurobindo Pharma Ltd. - Overview; Exhibits132: Aurobindo Pharma Ltd. - Product / Service; Exhibits133: Aurobindo Pharma Ltd. - Key offerings; Exhibits134: SWOT; Exhibits135: Biocon Ltd. - Overview; Exhibits136: Biocon Ltd. - Business segments; Exhibits137: Biocon Ltd. - Key offerings; Exhibits138: Biocon Ltd. - Segment focus; Exhibits139: SWOT; Exhibits140: Dhanuka Agritech Ltd. - Overview; Exhibits141: Dhanuka Agritech Ltd. - Business segments; Exhibits142: Dhanuka Agritech Ltd. - Key offerings; Exhibits143: Dhanuka Agritech Ltd. - Segment focus; Exhibits144: SWOT; Exhibits145: Dishman Carbogen Amcis Ltd. - Overview; Exhibits146: Dishman Carbogen Amcis Ltd. - Business segments; Exhibits147: Dishman Carbogen Amcis Ltd. - Key offerings; Exhibits148: Dishman Carbogen Amcis Ltd. - Segment focus; Exhibits149: SWOT; Exhibits150: Divis Laboratories Ltd. - Overview; Exhibits151: Divis Laboratories Ltd. - Product / Service; Exhibits152: Divis Laboratories Ltd. - Key offerings; Exhibits153: SWOT; Exhibits154: Jubilant Pharmova Ltd. - Overview; Exhibits155: Jubilant Pharmova Ltd. - Business segments; Exhibits156: Jubilant Pharmova Ltd. - Key news; Exhibits157: Jubilant Pharmova Ltd. - Key offerings; Exhibits158: Jubilant Pharmova Ltd. - Segment focus; Exhibits159: SWOT; Exhibits160: Lupin Ltd. - Overview; Exhibits161: Lupin Ltd. - Business segments; Exhibits162: Lupin Ltd. - Key news; Exhibits163: Lupin Ltd. - Key offerings; Exhibits164: Lupin Ltd. - Segment focus; Exhibits165: SWOT; Exhibits166: Merck and Co. Inc. - Overview; Exhibits167: Merck and Co. Inc. - Business segments; Exhibits168: Merck and Co. Inc. - Key news; Exhibits169: Merck and Co. Inc. - Key offerings; Exhibits170: Merck and Co. Inc. - Segment focus; Exhibits171: SWOT; Exhibits172: MSN Laboratories - Overview; Exhibits173: MSN Laboratories - Product / Service; Exhibits174: MSN Laboratories - Key offerings; Exhibits175: SWOT; Exhibits176: Onyx Scientific Ltd. - Overview; Exhibits177: Onyx Scientific Ltd. - Product / Service; Exhibits178: Onyx Scientific Ltd. - Key offerings; Exhibits179: SWOT; Exhibits180: Piramal Enterprises Ltd. - Overview; Exhibits181: Piramal Enterprises Ltd. - Product / Service; Exhibits182: Piramal Enterprises Ltd. - Key offerings; Exhibits183: SWOT; Exhibits184: Sun Pharmaceutical Industries Ltd. - Overview; Exhibits185: Sun Pharmaceutical Industries Ltd. - Product / Service; Exhibits186: Sun Pharmaceutical Industries Ltd. - Key news; Exhibits187: Sun Pharmaceutical Industries Ltd. - Key offerings; Exhibits188: SWOT; Exhibits189: TCG Lifesciences Pvt. Ltd. - Overview; Exhibits190: TCG Lifesciences Pvt. Ltd. - Product / Service; Exhibits191: TCG Lifesciences Pvt. Ltd. - Key offerings; Exhibits192: SWOT; Exhibits193: Wockhardt Ltd. - Overview; Exhibits194: Wockhardt Ltd. - Business segments; Exhibits195: Wockhardt Ltd. - Key offerings; Exhibits196: Wockhardt Ltd. - Segment focus; Exhibits197: SWOT; Exhibits198: Inclusions checklist; Exhibits199: Exclusions checklist; Exhibits200: Currency conversion rates for US$; Exhibits201: Research methodology; Exhibits202: Information sources; Exhibits203: Data validation; Exhibits204: Validation techniques employed for market sizing; Exhibits205: Data synthesis; Exhibits206: 360 degree market analysis; Exhibits207: List of abbreviations

Pricing

Currency Rates

Single User Online Download $2,500
Global Site License Online Download $4,000

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now